Home/Synendos Therapeutics/Prof. Dr. Jürg Gertsch
PD

Prof. Dr. Jürg Gertsch

Co-Founder

Synendos Therapeutics

Therapeutic Areas

Synendos Therapeutics Pipeline

DrugIndicationPhase
SYT-510General Anxiety Disorder (GAD), Post-Traumatic Stress Disorder (PTSD)Phase 1